C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98%
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

Relative Value

T5O doesn't have a meaningful market cap.

The Relative Value of one T5O stock under the Base Case scenario is 12.61 EUR. Compared to the current market price of 101.26 EUR, CytoTools AG is Overvalued by 88%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

T5O Relative Value
Base Case
12.61 EUR
Overvaluation 88%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
15
vs Industry
14
Median 3Y
2 574.3
Median 5Y
1 466.6
Industry
7.9
Forward
3 485.1
vs History
vs Industry
Median 3Y
-63.6
Median 5Y
-38.6
Industry
23.3
Forward
-12.9
vs History
vs Industry
Median 3Y
-32.8
Median 5Y
-32.8
Industry
22.8
vs History
vs Industry
Median 3Y
-32.8
Median 5Y
-32.8
Industry
26.4
vs History
39
vs Industry
78
Median 3Y
242.9
Median 5Y
235.2
Industry
2.6
vs History
15
vs Industry
17
Median 3Y
2 521.6
Median 5Y
1 423
Industry
7.6
Forward
3 413.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
Median 3Y
-63.4
Median 5Y
-43.9
Industry
4.7
vs History
vs Industry
Median 3Y
-61.9
Median 5Y
-43.2
Industry
4.3
Forward
-61.7
vs History
vs Industry
Median 3Y
-32.1
Median 5Y
-32.1
Industry
6.4
vs History
vs Industry
Median 3Y
-32.1
Median 5Y
-32.1
Industry
4.2
vs History
58
vs Industry
71
Median 3Y
257.4
Median 5Y
230.4
Industry
4.7

Multiples Across Competitors

T5O Competitors Multiples
CytoTools AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
CytoTools AG
XETRA:T5O
52.8m EUR 2 574.3 -79.9 -77.6 -75.4
US
Abbvie Inc
NYSE:ABBV
333B USD 6.1 62.9 15.4 23.6
US
Amgen Inc
NASDAQ:AMGN
172.6B USD 5.6 55.1 19.5 35.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.7B USD 12.4 -262.7 28 29.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
110.9B USD 8.2 25.7 22.3 24.7
US
Gilead Sciences Inc
NASDAQ:GILD
108.9B USD 3.9 103.4 9.8 12.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 923 -490.7 -534.4 -520.1
AU
CSL Ltd
ASX:CSL
145.3B AUD 6.6 36.8 22.5 28
US
Seagen Inc
F:SGT
39.3B EUR 18.5 -56.8 -61.1 -55.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
38B USD 16.2 -521.2 230.2 354.4
KY
Beigene Ltd
SSE:688235
250.9B CNY 11.3 -57.4 -35.6 -35.6
P/E Multiple
Earnings Growth
DE
C
CytoTools AG
XETRA:T5O
Average P/E: 56.8
Negative Multiple: -79.9
N/A
US
Abbvie Inc
NYSE:ABBV
62.9
406%
US
Amgen Inc
NASDAQ:AMGN
55.1
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -262.7
38%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.7
56%
US
Gilead Sciences Inc
NASDAQ:GILD
103.4
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -490.7 N/A
AU
CSL Ltd
ASX:CSL
36.8
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.8 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -521.2 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -57.4 N/A
EV/EBITDA Multiple
EBITDA Growth
DE
C
CytoTools AG
XETRA:T5O
Average EV/EBITDA: 49.7
Negative Multiple: -77.6
N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
19.5
64%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
22.3
53%
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
9%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.4 N/A
AU
CSL Ltd
ASX:CSL
22.5
42%
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
230.2
N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -35.6 N/A
EV/EBIT Multiple
EBIT Growth
DE
C
CytoTools AG
XETRA:T5O
Average EV/EBIT: 72.6
Negative Multiple: -75.4
N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
35.3
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.4
44%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
24.7
54%
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -520.1 N/A
AU
CSL Ltd
ASX:CSL
28
55%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
354.4
N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -35.6 N/A

See Also

Discover More
Back to Top